Senior Director, Vector Biology and Discovery Research at Vedere Bio - Cambridge, MA, US
Vedere Bio II, Inc.® is a company developing next generation ocular gene therapies designed for vision restoration and preservation for patients with vision loss due to photoreceptor death.